Electrodiffusional ATP movement through the cystic fibrosis transmembrane conductance regulator

被引:46
|
作者
Cantiello, HF
Jackson, GR
Grosman, CF
Prat, AG
Borkan, SC
Wang, YH
Reisin, IL
O'Riordan, CR
Ausiello, D
机构
[1] Massachusetts Gen Hosp E, Renal Unit, Charlestown, MA 02129 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[3] Boston Med Ctr, Renal Sect, Boston, MA 02118 USA
[4] Genzyme Corp, Framingham, MA 01701 USA
[5] Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Gen & Inorgan, RA-1113 Buenos Aires, DF, Argentina
来源
关键词
adenosine 5 '-triphosphate channels; adenosine 5 '-triphosphate-binding cassette transporters; nucleotide transport;
D O I
10.1152/ajpcell.1998.274.3.C799
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Expression of the cystic fibrosis transmembrane conductance regulator (CFTR), and of at least one other member of the ATP-binding cassette family of transport proteins, P-glycoprotein, is associated with the electrodiffusional movement of the nucleotide ATP. Evidence directly implicating CFTR expression with ATP channel activity, however, is still missing. Here it is reported that reconstitution into a lipid bilayer of highly purified CFTR of human epithelial origin enables the permeation of bath Cl- and ATP. Similar to previously reported data for in vivo ATP currents of CFTR-expressing cells, the reconstituted channels displayed competition between Cl- and ATP and had multiple conductance states in the presence of Cl- and ATP. Purified CFTR-mediated ATP currents were activated by protein kinase A and ATP (1 mM) from the "intracellular" side of the molecule and were inhibited by diphenylamine-2-carboxylate, glibenclamide, and anti-CFTR antibodies. The absence of CFTR-mediated electrodiffusional ATP movement may thus be a relevant component of the pleiotropic cystic fibrosis phenotype.
引用
收藏
页码:C799 / C809
页数:11
相关论文
共 50 条
  • [41] Cystic fibrosis transmembrane conductance regulator modulators for cystic fibrosis: a new dawn?
    Edmondson, Claire
    Course, Christopher William
    Doull, Iolo
    ARCHIVES OF DISEASE IN CHILDHOOD, 2021, 106 (10) : 941 - 945
  • [42] TARGETED ACTIVATION OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
    Villamizar, O.
    Waters, S.
    Scott, T.
    Saayman, S.
    Grepo, N.
    Urak, R.
    Davis, A.
    Morris, K.
    Jaffe, A.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S183 - S184
  • [43] Cystic fibrosis transmembrane conductance regulator mutations at a referral center for cystic fibrosis
    de Araujo Correia Coutinho, Cyntia Arivabeni
    de Lima Marson, Fernando Augusto
    Ribeiro, Antonio Fernando
    Ribeiro, Jose Dirceu
    Bertuzzo, Carmen Silvia
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2013, 39 (05) : 555 - 561
  • [44] Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
    Schmidt, BeLa Z.
    Haaf, Jeremy B.
    Leal, Teresinha
    Noel, Sabrina
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2016, 8 : 127 - 140
  • [45] Interactions of transmembrane helices in the cystic fibrosis transmembrane conductance regulator.
    Choi, MY
    Deber, CM
    BIOPHYSICAL JOURNAL, 2003, 84 (02) : 349A - 349A
  • [46] Cystic fibrosis transmembrane conductance regulator-emerging regulator of cancer
    Zhang, Jieting
    Wang, Yan
    Jiang, Xiaohua
    Chan, Hsiao Chang
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2018, 75 (10) : 1737 - 1756
  • [47] Differences between cystic fibrosis transmembrane conductance regulator and HisP in the interaction with the adenine ring of ATP
    Berger, AL
    Welsh, MJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (38) : 29407 - 29412
  • [48] Cystic fibrosis transmembrane conductance regulator-associated ATP release is controlled by a chloride sensor
    Jiang, QS
    Mak, D
    Devidas, S
    Schwiebert, EM
    Bragin, A
    Zhang, YL
    Skach, WR
    Guggino, WB
    Foskett, JK
    Engelhardt, JF
    JOURNAL OF CELL BIOLOGY, 1998, 143 (03): : 645 - 657
  • [49] The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke
    Raju, S. Vamsee
    Lin, Vivian Y.
    Liu, Limbo
    McNicholas, Carmel M.
    Karki, Suman
    Sloane, Peter A.
    Tang, Liping
    Jackson, Patricia L.
    Wang, Wei
    Wilson, Landon
    Macon, Kevin J.
    Mazur, Marina
    Kappes, John C.
    DeLucas, Lawrence J.
    Barnes, Stephen
    Kirk, Kevin
    Tearney, Guillermo J.
    Rowe, Steven M.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2017, 56 (01) : 99 - 108
  • [50] Cystic fibrosis transmembrane conductance regulator biomarkers in "real life': can we evaluate individual efficacy of cystic fibrosis transmembrane conductance regulator therapy?
    van Koningsbruggen-Rietschel, Silke
    Naehrlich, Lutz
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2015, 9 (04) : 198 - 200